MicroRNA-mediated drug resistance in breast cancer
Open Access
- 27 June 2011
- journal article
- website
- Published by Springer Science and Business Media LLC in Clinical Epigenetics
- Vol. 2 (2), 171-185
- https://doi.org/10.1007/s13148-011-0040-8
Abstract
Encompassing the broad spectrum of epigenetics research from basic research to innovations in therapeutic treatments, Clinical Epigenetics is a top tier, open ...Keywords
This publication has 141 references indexed in Scilit:
- miRNA-34a is associated with docetaxel resistance in human breast cancer cellsBreast Cancer Research and Treatment, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059JDNA Repair, 2010
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistanceDrug Resistance Updates, 2010
- miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in miceHepatology, 2010
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochemical Pharmacology, 2010
- The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cellsBreast Cancer Research and Treatment, 2010
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004